Drug recall · January 31, 2024
Febuxostat Tablets 80 mg recall
Why: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Febuxostat Tablets 80 mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-722-83.
- Lots / codes
Lot #s: DNE0867A Exp. 06/30/2025, DNE0894B Exp. 07/31/2025
- Quantity
- 19,992 bottles
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- January 18, 2024 · Voluntary: Firm initiated
- Classified
- January 25, 2024
- Reported
- January 31, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Febuxostat
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.